Cardiogenic Shock

Cardiogenic shock is the most severe form of acute heart failure: a state in which a primary cardiac problem reduces cardiac output so severely that tissue perfusion becomes inadequate despite adequate intravascular volume, producing hypotension and end-organ hypoperfusion. Acute myocardial infarction is its most common cause, and mortality is high.

Definition

Cardiogenic shock is a state of inadequate tissue perfusion resulting from primary cardiac dysfunction, characterised by persistent hypotension and signs of end-organ hypoperfusion despite adequate or elevated cardiac filling pressures.

Scope

This topic covers cardiogenic shock as the extreme of the heart-failure spectrum: its definition as primary pump failure causing hypoperfusion, its predominant cause in myocardial infarction, the SCAI staging that grades its severity, and the landmark trials that shaped understanding of revascularisation and mechanical support. It is an educational reference, not a treatment protocol.

Core questions

• What distinguishes cardiogenic shock from other shock states?
• Why is acute myocardial infarction its leading cause?
• How does the SCAI scheme stage shock severity?
• What did landmark trials reveal about revascularisation and mechanical circulatory support?

Key concepts

• Primary pump failure causing hypoperfusion
• Hypotension with end-organ hypoperfusion
• Acute myocardial infarction as leading cause
• SCAI shock stages (A through E)
• Mechanical circulatory support
• Spiral of hypoperfusion and ischaemia

Mechanisms

In cardiogenic shock a primary cardiac insult — most often a large myocardial infarction — sharply reduces stroke volume and cardiac output. Falling output lowers coronary and systemic perfusion, worsening myocardial ischaemia and further impairing contraction, which can establish a self-reinforcing downward spiral. Compensatory vasoconstriction and fluid retention raise filling pressures but cannot restore perfusion, and end organs become hypoperfused. The SCAI consensus stages this continuum from at-risk (stage A) through extremis (stage E), reflecting increasing severity of hypoperfusion.

Clinical relevance

Cardiogenic shock sits at the severe end of the heart-failure spectrum and carries high mortality, making its recognition and staging important for evidence appraisal in acute cardiovascular care. This entry describes the syndrome conceptually and is not a source of individualised diagnostic or treatment recommendations.

Epidemiology

Cardiogenic shock complicates a minority of acute myocardial infarctions but accounts for a large share of infarction-related deaths, with historically high in-hospital mortality. Its incidence and outcomes are tracked in major trial cohorts and registries.

Evidence & guidelines

Landmark trials shaped understanding of cardiogenic shock: SHOCK established the role of early revascularisation in infarction-related shock, IABP-SHOCK II questioned routine intra-aortic balloon counterpulsation, and ECLS-SHOCK examined extracorporeal life support. The SCAI consensus statement provides the contemporary severity classification. These are cited as reference and classification sources, not as treatment instructions.

History

Cardiogenic shock was long regarded as nearly uniformly fatal. The SHOCK trial in 1999 demonstrated a survival benefit from early revascularisation in infarction-related shock, shifting practice toward urgent reperfusion. Subsequent trials such as IABP-SHOCK II and ECLS-SHOCK critically tested mechanical support strategies, and the 2019 SCAI consensus introduced a standardised severity staging that reframed how the syndrome is described and studied.

Debates

What is the role of mechanical circulatory support?

Trials including IABP-SHOCK II and ECLS-SHOCK challenged the assumption that routine mechanical support improves survival in infarction-related cardiogenic shock, leaving the optimal use of these devices an area of ongoing investigation.

Key figures

• Judith Hochman
• Holger Thiele
• David Baran

Seminal works

• hochman-1999-shock
• thiele-2012-iabp
• baran-2019-scai

Frequently asked questions

How is cardiogenic shock different from other types of shock?

Cardiogenic shock results from the heart itself failing to pump enough blood (a pump problem), whereas other shock states arise from causes such as blood loss (hypovolaemic), infection (septic), or obstruction. In cardiogenic shock filling pressures are typically high rather than low.

What is the SCAI shock classification?

The SCAI scheme is a consensus framework that stages cardiogenic shock severity from stage A (at risk) through stage E (extremis), giving clinicians and researchers a standardised vocabulary for describing how severe a shock state is.